Safety and Feasibility of Carboplatin and Paclitaxel followed by Fluoropyrimidine Analogs and Radiation as Adjuvant Therapy for Gastric Cancer

Publisher： Karger

E-ISSN： 1662-6575|2|3|220-228

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.2, Iss.3, 2009-11, pp. : 220-228

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An appraisal of radiation therapy techniques for adjuvant and neoadjuvant therapy in gastric cancer

By  

Journal of Radiotherapy in Practice, Vol. 7, Iss. 2, 2008-06 ,pp. : 67-75

Cambridge University Press

Access to resources Recommend Favorite

Perspectives in Adjuvant Therapy of Gastric Cancer

By  

Oncology, Vol. 77, Iss. 1, 2010-02 ,pp. : 38-42

Karger

Access to resources Recommend Favorite

A Pilot Feasibility Study of TNFerade™ Biologic with Capecitabine and Radiation Therapy Followed by Surgical Resection for the Treatment of Rectal Cancer

By  

Oncology, Vol. 79, Iss. 5-6, 2011-03 ,pp. : 382-388

Karger

Access to resources Recommend Favorite

Intraperitoneal Paclitaxel Is Useful as Adjuvant Chemotherapy for Advanced Gastric Cancer with Serosal Exposure

By  

Case Reports in Oncology, Vol. 7, Iss. 1, 2014-01 ,pp. : 58-64

Karger

Access to resources Recommend Favorite

NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity‐modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer

By  

CANCER, Vol. 121, Iss. 13, 2015-07 ,pp. : 2156-2163

John Wiley & Sons Inc

Access to resources Recommend Favorite